BRAF Chromosome 7
B-Raf proto-oncogene, serine/threonine kinase
Upload your DNA to see your personal genotypes for variants in BRAF.
What This Gene Does
This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
Gene Info
Gene Group
"Mitogen-activated protein kinase kinase kinases|RAF family"
Locus Type
gene with protein product
Location
7q34
Ensembl
ENSG00000157764
Associated Conditions (98)
Dabrafenib response
Neoplasm
Noonan syndrome
RASopathy
Cardiovascular phenotype
6 conditions
Noonan syndrome and Noonan-related syndrome
BRAF-related disorder
Lung adenocarcinoma
Non-small cell lung carcinoma
Noonan syndrome 7
Epidermal nevus
Embryonal rhabdomyosarcoma
Cardio-facio-cutaneous syndrome
Noonan syndrome 1
LEOPARD syndrome 3
Cardiofaciocutaneous syndrome 1
Global developmental delay
7 conditions
See cases
+78 more conditions
Key Variants
RS1586126439
drug response
Dabrafenib response, Neoplasm, Dabrafenib response
Drug Response
RS1008080053
Conflicting classifications of pathogenicity
Noonan syndrome, RASopathy, Cardiovascular phenotype
Health Risk
RS1037323084
Conflicting classifications of pathogenicity
RASopathy, 6 conditions, RASopathy
Health Risk
RS1057518105
Conflicting classifications of pathogenicity
Health Risk
RS1057520665
Conflicting classifications of pathogenicity
RASopathy, RASopathy
Health Risk
RS1158725219
Conflicting classifications of pathogenicity
Noonan syndrome and Noonan-related syndrome, RASopathy, Cardiovascular phenotype
Health Risk
RS121913351
Conflicting classifications of pathogenicity
Lung adenocarcinoma, Non-small cell lung carcinoma, RASopathy
Health Risk
RS121913361
Conflicting classifications of pathogenicity
Noonan syndrome and Noonan-related syndrome, RASopathy, Noonan syndrome and Noonan-related syndrome
Health Risk
RS121913369
Conflicting classifications of pathogenicity
Non-small cell lung carcinoma, Noonan syndrome 7, Cardio-facio-cutaneous syndrome
Health Risk
RS1222192591
Conflicting classifications of pathogenicity
RASopathy, 6 conditions, Cardiovascular phenotype
Health Risk
RS1255101216
Conflicting classifications of pathogenicity
Cardiofaciocutaneous syndrome 1, Cardiofaciocutaneous syndrome 1
Health Risk
RS1320075163
Conflicting classifications of pathogenicity
RASopathy, RASopathy
Health Risk
All Variants (146)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS1586126439 | Drug Response | drug response | Dabrafenib response, Neoplasm, Dabrafenib response |
| RS1008080053 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome, RASopathy, Cardiovascular phenotype |
| RS1037323084 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, 6 conditions, RASopathy |
| RS1057518105 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS1057520665 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS1158725219 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome and Noonan-related syndrome, RASopathy, Cardiovascular phenotype |
| RS121913351 | Health Risk | Conflicting classifications of pathogenicity | Lung adenocarcinoma, Non-small cell lung carcinoma, RASopathy |
| RS121913361 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome and Noonan-related syndrome, RASopathy, Noonan syndrome and Noonan-related syndrome |
| RS121913369 | Health Risk | Conflicting classifications of pathogenicity | Non-small cell lung carcinoma, Noonan syndrome 7, Cardio-facio-cutaneous syndrome |
| RS1222192591 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, 6 conditions, Cardiovascular phenotype |
| RS1255101216 | Health Risk | Conflicting classifications of pathogenicity | Cardiofaciocutaneous syndrome 1, Cardiofaciocutaneous syndrome 1 |
| RS1320075163 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS1325951163 | Health Risk | Conflicting classifications of pathogenicity | Global developmental delay, Noonan syndrome and Noonan-related syndrome, Global developmental delay |
| RS142592480 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome 7, LEOPARD syndrome 3, RASopathy |
| RS1431556127 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, 6 conditions, RASopathy |
| RS145675911 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, 7 conditions |
| RS147732750 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS1481562268 | Health Risk | Conflicting classifications of pathogenicity | Cardiofaciocutaneous syndrome 1, RASopathy, Cardiofaciocutaneous syndrome 1 |
| RS1554403310 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS1562931107 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome, Cardiofaciocutaneous syndrome 1, Noonan syndrome |
| RS1562957000 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome 7, Noonan syndrome 7 |
| RS1585930903 | Health Risk | Conflicting classifications of pathogenicity | Cardiofaciocutaneous syndrome 1, RASopathy, Cardiofaciocutaneous syndrome 1 |
| RS1586015221 | Health Risk | Conflicting classifications of pathogenicity | Cardiofaciocutaneous syndrome 1, RASopathy, Cardiofaciocutaneous syndrome 1 |
| RS1586213318 | Health Risk | Conflicting classifications of pathogenicity | Cardiofaciocutaneous syndrome 1, RASopathy, Cardiofaciocutaneous syndrome 1 |
| RS1800507644 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, 6 conditions, RASopathy |
| RS180177040 | Health Risk | Conflicting classifications of pathogenicity | Cardiofaciocutaneous syndrome 1, Cardio-facio-cutaneous syndrome, RASopathy |
| RS1803835418 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, See cases, RASopathy |
| RS184144181 | Health Risk | Conflicting classifications of pathogenicity | LEOPARD syndrome 3, Noonan syndrome 7, RASopathy |
| RS200002171 | Health Risk | Conflicting classifications of pathogenicity | LEOPARD syndrome 3, RASopathy, Noonan syndrome 7 |
| RS2129044317 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS2536007419 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome 7, Noonan syndrome |
| RS34776339 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS371857758 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome and Noonan-related syndrome, RASopathy |
| RS397507457 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, RASopathy |
| RS397507458 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome, BRAF-related disorder |
| RS397507464 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, RASopathy |
| RS397507467 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome and Noonan-related syndrome, RASopathy, RASopathy |
| RS397507478 | Health Risk | Conflicting classifications of pathogenicity | Cardiofaciocutaneous syndrome 1, Noonan syndrome 7, RASopathy |
| RS397516900 | Health Risk | Conflicting classifications of pathogenicity | Cardiovascular phenotype, RASopathy, Cardiovascular phenotype |
| RS527835644 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome and Noonan-related syndrome, RASopathy, Noonan syndrome and Noonan-related syndrome |
| RS557241012 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiofaciocutaneous syndrome 1, Noonan syndrome 1 |
| RS56092510 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome 7, LEOPARD syndrome 3 |
| RS587778114 | Health Risk | Conflicting classifications of pathogenicity | LEOPARD syndrome 3, RASopathy, Noonan syndrome 7 |
| RS727502904 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome, Cardio-facio-cutaneous syndrome, Noonan syndrome 7 |
| RS727504375 | Health Risk | Conflicting classifications of pathogenicity | Cardio-facio-cutaneous syndrome, Noonan syndrome, RASopathy |
| RS730880411 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Noonan syndrome and Noonan-related syndrome, RASopathy |
| RS745783052 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Primary dilated cardiomyopathy, 6 conditions |
| RS749792302 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, Cardiovascular phenotype, 6 conditions |
| RS750556299 | Health Risk | Conflicting classifications of pathogenicity | RASopathy, 6 conditions, Nonpapillary renal cell carcinoma |
| RS753545284 | Health Risk | Conflicting classifications of pathogenicity | Noonan syndrome and Noonan-related syndrome, RASopathy, Noonan syndrome and Noonan-related syndrome |